Latest filing published 12 Jan 2021 for Lexaria Bioscience Corp..
Insider track record
No signal scores available.
Allan Horst Spissinger: trading record in brief
All filings by Allan Horst Spissinger on record concern Lexaria Bioscience Corp. We count 2 filings; the first trade dates from 15 February 2019 and the latest from 11 January 2021.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 12 January 2021, reports a transaction in Lexaria Bioscience Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Allan Horst Spissinger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,972 sharesCommon SharesTSXSEDI:3661632
- 50,000 shares@ CA$0.37100.0% of flowCommon SharesTSXSEDI:3317194
2 of 2 declarations